News About: Pharm. Industry
Imported generic drugs are coming in Korea market
Imported generic drugs are coming in Korea market. Domestic pharmaceutical companies which were dependent on domestic sales through generic production faced another competition.
On July 21, Bi-nex announced that they...
Mid-sized pharmaceutical companies recorded overall 6% increase of prescription sales in the first half of this year
According to the analysis of prescribing performance of mid-sized pharmaceutical companies (sales of 20~75 billion won range, Ubist based) in the first half of this year, they recorded overall 6% increase in prescript...
LG Life Sciences announced that they invest a total of 132.1 billion won for constructing research complex
On July 22, LG Life Sciences announced that they invest a total of 132.1 billion won for constructing research complex. The investment accounts for 53.9% of equity capital of LG Life Sciences (245,274,804,469 won).
L...
Huons announced that they held the completion ceremony of 'Huonland Tongzhou GMP Plant' which is located in China
On July 22, Huons announced that they held the completion ceremony of 'Huonland Tongzhou GMP Plant' which is located in China, Beijing Tongzhou on last July 18.
Huons plan to start to begin its first production in Ju...
Celltrion announced that they received the final analysis of additional clinical results of Remsima from Contract Research Organization for its applying for U.S. approval
On July 21, Celltrion announced that they received the final analysis of additional clinical results of Remsima from Contract Research Organization for its applying for U.S. approval.
Celltrion plans to apply for sal...
Hanmi Pharmaceutical announced that they signed an export contract of injectable arthritis drug 'Hyalrheuma' with U.S. company Actavis
On July 21, Hanmi Pharmaceutical announced that they signed an export contract of injectable arthritis drug 'Hyalrheuma' with the no.1 U.S. generic pharmaceutical company Actavis (President Paul Bisaro).
Through the ...
It was identified that the most drug product produced by pharmaceutical companies in last year was Circulatory agents
It was identified that the most drug product produced by pharmaceutical companies in last year was Circulatory agents, followed by Drugs for central nervous system, and Agents for digestive organ in order.
According ...
Chief Executive Officer of Teva-Handok, Hong Yoo-Suk was elected as a president of GSK Korea
Chief Executive Officer of Teva-Handok, Hong Yoo-Suk was elected as a president of GSK Korea. Kim Jin-ho, the current representative director of GlaxoSmithKline Korea was elected as chairman.
Chairman Kim Jin-ho was ...
It is identified that 2~3 cases of M & A between pharmaceutical companies are taking place
On July 21, according to the related industry, it is identified that 2~3 cases of M & A between pharmaceutical companies are taking place under the surface of the water.
One industry official said, "There are incre...
The number of pharmaceutical companies which produce drug product decreased, but the number of companies which produce quasi drug increased
It was identified that last year, the number of pharmaceutical companies which produce drug product decreased, but the number of companies which produce quasi drug increased.
According to the 'Productivity performanc...
